A meta-analysis of over 10 articles examining the link between cancer and cannabis use found benefits for cancer patients: reduced pain and nausea, increased appetite, and potential action against cancer cells themselves.
This is attributed to the anti-inflammatory effects of cannabis components. The researchers hope that their findings will encourage relaxation of restrictions on the use of cannabis in the support of cancer patients, as well as attention to research into its anti-cancer properties. Research published in the journal Frontiers in Oncology.
Researchers conducted the largest meta-analysis of the effects of cannabis on cancer patients, with 10 times more data than previous studies. They looked at clinical trials of cannabis-based drugs, epidemiological studies of cannabis-related cancer, and preclinical studies in cell cultures and animals. The evidence for the benefits of medical cannabis for cancer patients was more than 30 times stronger than the evidence for its harms.
Specifically, researchers found a weak positive association of cannabis use with increased appetite, reduced inflammation, nausea, pain, and opioid use, as well as a moderate positive association with overall improvement. The effects of cannabis on inflammation may also be used in the treatment of other chronic diseases associated with impaired immune response, such as autoimmune diseases.
Thank you for being with us! Monobank for the support of the ElitExpert editorial office.
